Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis

Cutis

Volumn 78, Issue 5, 2006, Pages 357-363

  Hebert, Adelaide A ^a,e,f   Koo, John ^b,e,f   Fowler, Joseph ^c,e   Berman, Brian ^d,e   Rosenberg, Carl ^e   Levitt, Jacob ^e,g  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PSC   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Taro Pharmaceuticals USA Inc   (United States)

^f ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845619832     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bowman PH, Maloney JE, Koo JY. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. J Am Acad Dermatol. 2002;46:907-913.
2. Lebwohl M. Vitamin D and topical therapy. Cutis. 2002;70(suppl 5):5-8.
3. Lebwohl M, Ali S. Treatment of psoriasis, part 1: topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487-498.
4. Patel B, Siskin S, Krazmien R, et al. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol. 1998;38:1010-1011.
5. Hecker D, Worsley J, Yueh G, et al. In vitro compatibility of tazarotene with other topical treatments of psoriasis. J Am Acad Dermatol. 2000;42:1008-1011.
6. Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976;95:323-328.
7. Furue M, Terao H, Moroi Y, et al. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J Dermatol. 2004;31:277-283.
8. Torok HM, Maas-Irslinger R, Slayton RM. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. Cutis. 2003;72:161-166.
9. Levitt J, Feldman T, Riss I, et al. Compatibility of desoximetasone and tacrolimus. J Drugs Dermatol. 2003;2:640-642.
10. Murray L, ed. Physicians' Desk Reference. 59th ed. Montvale, NJ: Thomson PDR; 2005.
11. Zar JH. Paired sample hypotheses. In: Zar JH. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, Inc; 1984:150-161.
12. SAS Institute Inc. SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute Inc; 1990.
13. Wolverton SE. Comprehensive Dermatologic Therapy. New York, NY: WB Saunders Company; 2001.
14. Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. New York, NY: Mosby; 2003.
15. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002;46:228-241.
16. Koo J. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol. 1999;41(3 pt 2):S25-S28.
17. Short MW, Vaughan TK. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis. Cutis. 2004;74:185-188.